Loading
Latest filing published 21 Jun 2024 for Sonoma Pharmaceuticals, Inc..
No signal scores available.
Poggetto John Dal is a declared insider of Sonoma Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 23 April 2020 to 20 June 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 21 June 2024: a share grant, in Sonoma Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations